Schedule 13G ownership disclosure

Castle Biosciences Inc

Common Stock · CUSIP: 14843C105

Event date: 2025-09-30

Filing-level shares
1,474,089.00
Percent of class
5.1%
  • Dimensional Fund Advisors LP

    Shares: 1,474,089.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000354204-25-001269
Form type
SCHEDULE 13G
Filer
CASTLE BIOSCIENCES INC
CIK
CIK 1447362
Filed
Oct 09, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub